FBP1 and renal cell carcinoma: In our study, we found that activation of the tumor suppressor FBP1 by miR-24-1 can inhibit Warburg effect in RCC, suggesting that blockade of metabolic processes such as Warburg effect through miR-24-1 constitutes a good therapeutic strategy for RCC.